quinazolines has been researched along with Arachnoidal Cerebellar Sarcoma, Circumscribed in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Alimova, I; Balakrishnan, I; Donson, A; Erlander, M; Foreman, NK; Fosmire, S; Joshi, M; Madhavan, K; Pierce, A; Ridinger, M; Sullivan, KD; Venkataraman, S; Veo, B; Vibhakar, R; Wang, D | 1 |
| Bolin, S; Borgenvik, A; Bradner, JE; Cho, YJ; Persson, CU; Qi, J; Sundström, A; Swartling, FJ; Weishaupt, H; Weiss, WA | 1 |
| Blaney, SM; Boyett, JM; Fouladi, M; Gajjar, A; Geyer, JR; Gilbertson, RJ; Goldman, S; Kun, LE; Onar-Thomas, A; Packer, RJ; Schaiquevich, P; Stewart, CF | 1 |
| Bebenek, M; Bryant, M; Diaz, RJ; Faria, C; Golbourn, B; Huang, A; Leadly, M; MacKenzie, D; Picard, D; Raynaud, D; Rutka, JT; Shih, D; Smith, CA; Taylor, MD | 1 |
| Alimova, I; Birks, D; Donson, A; Foreman, NK; Harris, P; Ng, J; Taylor, MD; Venkataraman, S; Vibhakar, R | 1 |
| Craveiro, RB; Dilloo, D; Ehrhardt, M; Goetz, B; Olschewski, M; Pietsch, T; Velz, J | 1 |
| Cusano, G; Ferlini, C; Giangaspero, F; Meco, D; Riccardi, A; Riccardi, R; Servidei, T; Zannoni, GF | 1 |
| Abraham, J; Davare, MA; Giles, FJ; Hanes, MA; Keller, C; Kilcoyne, A; Lal, S; Nelon, LD; Ohshima-Hosoyama, S; Prajapati, SI; Rubin, BP | 1 |
1 trial(s) available for quinazolines and Arachnoidal Cerebellar Sarcoma, Circumscribed
| Article | Year |
|---|---|
A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study.
Topics: Adolescent; Antineoplastic Agents; Blotting, Western; Central Nervous System Neoplasms; Child; Child, Preschool; Ependymoma; ErbB Receptors; Female; Glioma; Humans; Infant; Lapatinib; Male; Medulloblastoma; Neoplasm Grading; Quinazolines; Treatment Outcome; Young Adult | 2013 |
7 other study(ies) available for quinazolines and Arachnoidal Cerebellar Sarcoma, Circumscribed
| Article | Year |
|---|---|
A novel PLK1 inhibitor onvansertib effectively sensitizes MYC-driven medulloblastoma to radiotherapy.
Topics: Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms; Child; G2 Phase Cell Cycle Checkpoints; Humans; Medulloblastoma; Piperazines; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pyrazoles; Quinazolines | 2022 |
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
Topics: Azepines; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cerebellar Neoplasms; Cyclin-Dependent Kinase 2; Drug Synergism; Female; Humans; Medulloblastoma; Piperazines; Protein Kinase Inhibitors; Protein Stability; Proto-Oncogene Proteins c-myc; Pyrazoles; Pyridines; Quinazolines; Sequence Analysis, RNA; Signal Transduction; Triazoles; Xenograft Model Antitumor Assays | 2018 |
Mechanism of action and therapeutic efficacy of Aurora kinase B inhibition in MYC overexpressing medulloblastoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aurora Kinase B; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; Medulloblastoma; Mice, Nude; Molecular Targeted Therapy; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-myc; Quinazolines; Signal Transduction; Time Factors; Transfection; Tumor Burden; Up-Regulation; Xenograft Model Antitumor Assays | 2015 |
MPS1 kinase as a potential therapeutic target in medulloblastoma.
Topics: Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; M Phase Cell Cycle Checkpoints; Medulloblastoma; Mitosis; Molecular Targeted Therapy; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyrazoles; Quinazolines | 2016 |
The anti-neoplastic activity of Vandetanib against high-risk medulloblastoma variants is profoundly enhanced by additional PI3K inhibition.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cerebellar Neoplasms; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Humans; Indazoles; Medulloblastoma; Molecular Targeted Therapy; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Sulfonamides | 2017 |
Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Epidermal Growth Factor; ErbB Receptors; Flow Cytometry; Gefitinib; Gene Expression; Humans; Male; Medulloblastoma; Mice; Mice, Nude; Proto-Oncogene Proteins c-akt; Quinazolines; Receptor, ErbB-2; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Xenograft Model Antitumor Assays | 2009 |
Preclinical testing of tandutinib in a transgenic medulloblastoma mouse model.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Separation; Cerebellar Neoplasms; Disease Models, Animal; Flow Cytometry; Immunohistochemistry; Medulloblastoma; Mice; Mice, Transgenic; Piperazines; Quinazolines; Receptor, Platelet-Derived Growth Factor alpha; Reverse Transcriptase Polymerase Chain Reaction | 2012 |